American International Group, Inc. Acumen Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.08 - $4.88 $43,264 - $68,549	-14,047 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.91 - $6.73 $34,063 - $58,631	8,712 Added 163.3%	14,047 $55,000
Q4 2021 Feb 11, 2022	BUY	$6.54 - $15.31 $575 - $1,347	88 Added 1.68%	5,335 $36,000
Q3 2021 Nov 12, 2021	BUY	$14.5 - $20.28 $76,081 - $106,409	5,247 New	5,247 $78,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $89.1M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.